PDCO logo

Patterson Companies Inc. (PDCO)

$31.33

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PDCO

Market cap

$2.77B

EPS

1.55

P/E ratio

20.2

Price to sales

0.43

Dividend yield

3.32%

Beta

0.735614

Price on PDCO

Previous close

$31.33

Today's open

--

Day's range

--

52 week range

$19.45 - $31.79

Profile about PDCO

CEO

Donald J. Zurbay

Employees

7600

Headquarters

Saint Paul, MN

Exchange

Nasdaq Global Select

Shares outstanding

88474000

Issue type

Common Stock

PDCO industries and sectors

Healthcare

Medical Distributors

News on PDCO

Wall Street's Most Accurate Analysts Give Their Take On 3 Energy Stocks With Over 4% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

news source

Benzinga • Nov 26, 2025

news preview

Patterson Companies Completes Acquisition by Patient Square Capital

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (“Patterson” or the “Company”), a leading supplier of products and services to the dental and animal health end markets, successfully completed its acquisition by Patient Square Capital (“Patient Square”), a dedicated health care investment firm, on April 17, 2025. As a result of this transaction, Patterson's common stock is no longer traded on the NASDAQ Global Select Market. In conjunction with the closing of the acquisition, Patterson is.

news source

Business Wire • Apr 22, 2025

news preview

Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (NASDAQ: PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, “I would like to express my gratitude t.

news source

Business Wire • Apr 1, 2025

news preview

Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?

Patterson Cos. (PDCO) reported earnings 30 days ago.

news source

Zacks Investment Research • Mar 28, 2025

news preview

PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract

Patterson Companies' overall top-line figure for the third quarter of fiscal 2025 reflects weak segmental performance.

news source

Zacks Investment Research • Feb 27, 2025

news preview

Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. “As we continue to progress toward closing our transaction with Patient Square Capital, our team remains focused on executing our strategy,” said Don Zurbay, President and CEO of Patterson Companies. “While our third quarter results were impacted by challenging market conditions, we remain confident in the long-term strength of Pat.

news source

Business Wire • Feb 26, 2025

news preview

Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates

Patterson Cos. (PDCO) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.62 per share.

news source

Zacks Investment Research • Feb 27, 2025

news preview

PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns wheth.

news source

Business Wire • Feb 25, 2025

news preview

Patterson Companies Announces Expiration of “Go-Shop” Period

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. (“Patient Square”), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinanc.

news source

Business Wire • Jan 21, 2025

news preview

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

news source

GlobeNewsWire • Jan 6, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Patterson Companies Inc.

Open an M1 investment account to buy and sell Patterson Companies Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PDCO on M1